Founded in 2018, Rymedi is revolutionizing data transfer and security on a global scale. The Rymedi blockchain platform meets multijurisdictional compliance so that data is securely transferred while meeting healthcare compliance standards worldwide. With over 1 million lives on the platform in over 1,200 locations in the US, Africa, and Australia, it is utilized for occupational health, laboratories, diagnostic devices, and clinical trials.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/27/23 | $9,000,000 | Series A |
Blockchange Ventures RW3 Ventures  White Star Capital | undisclosed |
